Report #2894319

Received Apr 27, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 19 yrs
State: NY
Recovered: Unknown
Vaccinated: Jan 19, 2026
Onset: Jan 19, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	3	9K74F	—

Symptoms (1)

Expired product administered

Symptom narrative

Inadvertent administration of an expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HBV (Engerix B 10 mcg) (batch number 9K74F, expiry date 27-OCT-2025) for prophylaxis. On 19-JAN-2026, the patient received the 3rd dose of Engerix B 10 mcg. On 19-JAN-2026, an unknown time after receiving Engerix B 10 mcg, the patient experienced expired vaccine used (Verbatim: Inadvertent administration of an expired dose). Additional Information: GSK Receipt Date: 20-APR-2026 The reporter (practice administrator) reported the administration of an expired dose of Engerix-B. The expiration date of the vaccine was 27-OCT-2025 and the vaccine was administered on 19-JAN-2026. This was the patient's third dose of Engerix-B.; Sender's Comments: GSK-US2026054154:Same reporter/Diffrent patient